Switzerland Swissmedic Medical Device Registration Guide (2026)

Why Switzerland Matters for Medical Device Manufacturers

Switzerland has a population of nearly 9 million and one of the highest per-capita healthcare expenditures in the world. Its IVD market leads Europe in per-capita spending (€88.9 per person in 2021), and the overall Swiss medical device market is growing steadily. The country is home to major medtech companies and serves as a strategic European market in its own right.

However, since May 2021, Switzerland is no longer part of the EU single market for medical devices. The Mutual Recognition Agreement (MRA) between the EU and Switzerland — which had allowed CE-marked devices to flow freely across the Swiss border — lapsed when the EU MDR came into force and negotiations to update Chapter 4 of the MRA failed. The EU now treats Switzerland as a third country for medical devices. The same happened for IVDs in May 2022 when the IVDR became applicable.

This means manufacturers must now comply with a standalone Swiss regulatory framework governed by the Medical Devices Ordinance (MedDO, SR 812.213) and the Ordinance on In Vitro Diagnostic Medical Devices (IvDO, SR 812.219), both of which are largely based on the EU MDR and IVDR but include Swiss-specific requirements.

Regulatory Framework Overview

Key Legislation

Swiss legislation closely mirrors the EU MDR and IVDR. Common Specifications become legally valid in Switzerland after Swissmedic designates them and publishes them in the Federal Gazette. Relevant EU implementing and delegated acts can be adopted when the Swiss Federal Council declares them directly applicable — but only for technical or administrative details regulated on an ongoing basis.

Swissmedic

Swissmedic, the Swiss Agency for Therapeutic Products, is the regulatory authority responsible for medical devices. It is affiliated with the Swiss Federal Department of Home Affairs. Since the MRA lapse, Swissmedic no longer has access to EUDAMED and has developed its own database: swissdamed.

Swiss-Specific Differences from EU MDR

While the Swiss framework is fundamentally aligned with the EU MDR, several differences exist:

• Swiss Authorized Representative (CH-REP): Foreign manufacturers must appoint a Swiss-based representative — an EU EC-REP is not sufficient

• Swiss Importer: A distinct role with separate obligations from the CH-REP

• swissdamed: Switzerland's own database, separate from EUDAMED, with its own registration requirements and timelines

• Labeling: Swiss importer information can appear on delivery notes, guarantee certificates, customs documents, or invoices — not necessarily on the device labeling itself (a broader interpretation than the EU's)

• Permanent labeling simplification for certain IVDs: IVDs not intended for self-testing and not usable by laypersons benefit from permanently eased labeling requirements (effective January 1, 2025)

Classification

Switzerland uses the same risk-based classification system as the EU:

Medical Devices (MedDO)

IVDs (IvDO)

Classification follows the same rules as EU MDR Annex VIII (for devices) and IVDR Annex VIII (for IVDs). The 22 classification rules for medical devices and the 7 classification rules for IVDs apply identically.

Step-by-Step Registration Process

Step 1: Obtain CE Marking

All medical devices and IVDs placed on the Swiss market must bear the EU CE mark. The conformity assessment process — including generating a technical documentation file and quality management system — is based on EU MDR or IVDR requirements. Swissmedic does not conduct its own conformity assessment for devices bearing a valid CE certificate from an EU Notified Body.

Step 2: Appoint a Swiss Authorized Representative (CH-REP)

All manufacturers based outside Switzerland must appoint a Swiss Authorized Representative (CH-REP). This is mandatory and is one of the most significant changes since the MRA lapse.

CH-REP Requirements:

• Must be established in Switzerland (or Liechtenstein, due to the Customs Treaty)

• Must be designated in a written mandate from the manufacturer

• Must register in swissdamed to obtain a CH Registration Number (CHRN)

• Acts as the regulatory contact point for Swissmedic

CH-REP Obligations:

• Verify that the device complies with MedDO/IvDO requirements

• Maintain a copy of the technical documentation, DoC, and QMS certificates

• Register devices in swissdamed (when mandatory)

• Cooperate with Swissmedic on vigilance and post-market matters

• Provide Swissmedic with documentation upon request

Best Practice: Choose a CH-REP independent from your Swiss distributor. This reduces regulatory impact when changing distributors, since CH-REP information must accompany devices.

Step 3: Appoint a Swiss Importer

The Swiss Importer is a separate economic operator role from the CH-REP. The importer is the entity established in Switzerland that places a device from a third country onto the Swiss market.

Importer Obligations:

• Register in swissdamed to obtain a CHRN

• Verify that the manufacturer has appointed a CH-REP

• Verify that CE marking and labeling requirements are met

• Maintain records of devices placed on the Swiss market

• Inform Swissmedic of non-compliant devices

Labeling Requirement: The Swiss importer's information must be supplied with the device — on the label, instructions for use, or in a "document accompanying the device." Swissmedic's interpretation of "document accompanying the device" is broader than the EU's: it includes delivery notes, guarantee certificates, customs documents, or invoices. Unlike the EU, Swissmedic does not require this document to reach the end user.

Step 4: Register Economic Operators in swissdamed

swissdamed is Switzerland's medical device database, developed as a replacement for access to EUDAMED. Economic operator registration has been mandatory since August 2024.

Who Must Register:

Registration produces a CH Registration Number (CHRN), analogous to the EU's SRN. This number is used for all subsequent interactions with Swissmedic and swissdamed.

Step 5: Device Registration in swissdamed (Mandatory July 1, 2026)

The device registration module in swissdamed becomes mandatory on July 1, 2026, with a transition period until December 31, 2026. This aligns approximately one month after the EU's EUDAMED mandatory registration date (May 28, 2026).

What Must Be Registered:

• All medical devices, IVDs, systems, and procedure packs placed on the Swiss market from July 1, 2026 onward

• Legacy devices (devices under old legislation per Art. 101 MedDO) that continue to be placed on the market

• Devices subject to vigilance actions (must be registered by July 1, 2026 — no transition period extension)

Registration Process:

• Device data is uploaded to swissdamed via the UDI Devices module

• Data format is similar to EUDAMED's UDI/Device module

• XML files can be prepared in advance for uploading

• Voluntary registration is currently available and encouraged

Fees: Swissmedic will charge a one-time registration fee for devices registered in swissdamed. The first invoicing is planned for January 2027 for devices registered by the end of 2026. The exact fee amount has not yet been published.

Step 6: Device Notification (Pre-July 2026 Requirement)

Until the swissdamed device registration becomes mandatory on July 1, 2026, certain devices must still be notified to Swissmedic under the existing notification system:

Devices Requiring Notification:

Notification Fee: CHF 300 per notification, with an additional administrative fee of CHF 200/hour in cases involving incomplete documentation, withdrawn applications, or corrections.

Processing Time: Approximately one month from receipt, assuming no questions from Swissmedic. The notification obligation is fulfilled upon submission.

From January 1, 2027, only individual device notifications for custom-made devices (per Art. 19 MepV) will remain under the notification system.

Fees and Costs

Published pricing benchmark: Switzerland is listed as a partner market in the third-party price file. The CH-REP annual flat-fee benchmark starts at $2,000/year for one registration and scales to $4,000/year for five registrations, with 6+ registrations quoted separately. Swissdamed device registration fees are still listed as TBD, while custom-made device notification is listed at CHF 300. See Pure Global pricing.

Swissmedic Fees

Estimated Total Costs for Foreign Manufacturers

Comparison to EU Costs

Switzerland does not add a separate conformity assessment layer for devices with valid EU CE certificates. The primary additional costs versus selling in the EU are the CH-REP fees and swissdamed registration.

Vigilance and Post-Market Requirements

Swissmedic's vigilance reporting requirements are analogous to those in the EU:

Reporting Obligations

Manufacturers (or their CH-REP) must submit vigilance reports to Swissmedic using the designated forms. Swissmedic published updated forms for incidents and FSCAs in March 2026.

Post-Market Surveillance

Post-market surveillance obligations under MedDO/IvDO mirror the EU MDR/IVDR requirements:

• Post-market surveillance plans per MedDO requirements

• PMCF/clinical follow-up as applicable

• PSUR reporting according to device class

• Trend reporting and analysis

swissdamed vs. EUDAMED

Manufacturers marketing in both the EU and Switzerland must register in both databases separately. However, the data structures are similar, so XML files prepared for EUDAMED can largely be reused for swissdamed with appropriate modifications.

Timeline Summary

Liechtenstein

Under the Customs Treaty between Switzerland and the Principality of Liechtenstein, medical devices placed on the market in Liechtenstein are governed by the Swiss MedDO and IvDO. Liechtenstein-based economic operators must register with Swissmedic and comply with the same requirements as Swiss-based operators.

Future Developments

Swissmedic is actively exploring mutual recognition pathways beyond the EU, including potential pathways with the US (FDA), Japan (PMDA), and Canada. This could create faster market access for devices already cleared in those jurisdictions. Manufacturers should monitor Swissmedic communications for updates on these evolving pathways.

Swissmedic is also hosting a free webinar on May 28, 2026, on how to register and manage medical device data in swissdamed — a valuable resource for manufacturers preparing for mandatory registration.

FAQ

Do I need a separate conformity assessment for Switzerland? No. If your device has a valid EU CE certificate from a Notified Body, Swissmedic accepts that. You do not need to undergo a separate Swiss conformity assessment.

Can my EU EC-REP also serve as my Swiss CH-REP? No. The CH-REP must be established in Switzerland (or Liechtenstein). An EU-based EC-REP cannot fulfill this role. However, some regulatory service providers offer both EC-REP and CH-REP services.

Does my Class I device need to be registered in swissdamed? From July 1, 2026, yes — all devices placed on the Swiss market must be registered in swissdamed, regardless of class. Before that date, only Swiss-manufactured Class I devices needed to be notified.

What happens if I miss the swissdamed registration deadline? Devices subject to vigilance actions must be registered by July 1, 2026 with no extension. For all other devices, the transition period runs through December 31, 2026. After that, non-registered devices cannot legally be placed on the Swiss market.

Do I need to translate my labeling into Swiss languages? Switzerland has three official languages for medical device information: German, French, and Italian. The labeling and IFU language requirements should be evaluated based on the cantons where the device will be distributed.

How does the Swiss importer differ from the EU importer? Both roles verify compliance and maintain records. However, Swissmedic accepts a broader range of documents as "accompanying the device" (including delivery notes and invoices), and does not require this information to reach the end user.